NR 546 Advanced Psychopharmacology Midterm Exam:
(Latest 2026/2027 Update) Neuroanatomy, CYP450,
Antipsychotics, Neurotransmitters | Q&A | Grade A | 100%
Correct Verified Answers
Subject: Advanced Psychopharmacology – Functional Neuroanatomy (Frontal Lobe, Wernicke's Area,
Broca's Area, Hippocampus, Basal Ganglia, Limbic System, Temporal Lobe, Occipital Lobe,
Gray/White Matter); Neurotransmitters (Dopamine, Serotonin, Norepinephrine, GABA, Acetylcholine,
Glutamate); Dopamine Pathways (Mesolimbic, Nigrostriatal, Mesocortical, Tuberoinfundibular);
CYP450 Inducers/Inhibitors; Pharmacokinetics (Steady State, Half-Life); Pharmacodynamics (Agonist,
Partial Agonist, Antagonist, Inverse Agonist); First-Generation Antipsychotics (FGAs) – Positive
Symptoms, EPS, Hyperprolactinemia; Second-Generation Antipsychotics (SGAs) – Clozapine,
Risperidone, Olanzapine, Quetiapine, Aripiprazole, Lurasidone, Ziprasidone, Asenapine, Iloperidone,
Paliperidone; Adverse Effects (NMS, Tardive Dyskinesia, Akathisia, Dystonia, QT Prolongation,
Metabolic Syndrome); Beers Criteria; Epigenetics; Informed Consent; Extrapyramidal Symptoms
(EPS); Hyperprolactinemia; Galactorrhea; Smoking and Antipsychotic Metabolism; Grapefruit Juice
Interactions; Pharmacogenomics (Extensive Metabolizer, Poor Metabolizer, Rapid Metabolizer);
Tolerance; SSRI Discontinuation Syndrome.
Source: NR 546 Midterm Blueprint 2026, Stahl's Essential Psychopharmacology, APA Guidelines.
Format: Q&A Guide with Clinical Rationale | Verified Answers | Grade A Guaranteed
Which of the following data is most accurate in determining a treatment plan for a patient who
presents with depression?
Correct Answer: The patient states that they are experiencing feelings of sadness, insomnia, and
lack of appetite (subjective patient report is primary in depression diagnosis).
1. Depression diagnosis is clinical (DSM-5 criteria). Lab tests cannot diagnose depression. Patient-
reported symptoms guide treatment selection.
Informed Consent in psychiatric practice
Correct Answer: Clients have the right to receive enough information to make decisions about their
treatment. Must be informed about potential risks associated with medication. Clients have the right
to refuse treatment and cannot be forcibly medicated in non-emergencies.
1. Elements: disclosure of risks/benefits, alternatives, risks of no treatment; competency; voluntariness.
2. Exceptions: emergency (danger to self/others), court order, legally mandated treatment.
Which lobe is responsible for movement and intelligence and can result in personality changes
if damaged?
Correct Answer: Frontal Lobe
1. Frontal lobe: motor cortex, executive function (planning, organization, abstract thinking), personality,
behavior, emotional control. Damage causes personality changes, disinhibition, apathy, poor judgment.
, PMHNP wants to prescribe olanzapine for depression. Client takes amiodarone for atrial
fibrillation. What does PMHNP need to do?
Correct Answer: Decrease the dosage of olanzapine (amiodarone is CYP450 inhibitor, reduces
olanzapine metabolism, risk of toxicity).
1. Amiodarone inhibits CYP3A4, CYP2D6, CYP2C9. Olanzapine metabolized by CYP1A2, CYP2D6.
Inhibition leads to increased olanzapine levels.
What NTM is responsible for a patient's diagnosis of Parkinson's?
Correct Answer: Dopamine (low dopamine in nigrostriatal pathway causes Parkinson's motor
symptoms).
1. Dopamine affects balance and coordination. Low levels found in Parkinson's. Treatment:
levodopa/carbidopa, dopamine agonists.
Where does Naloxone fall on the agonist spectrum?
Correct Answer: Antagonist (binds to opioid receptors, blocks endogenous opioids, no intrinsic
activity, reverses opioid effects).
1. Naloxone is competitive antagonist at mu-opioid receptor. Precipitates withdrawal in opioid-dependent
patients.
Medications for schizophrenia target which main neurotransmitter?
Correct Answer: Dopamine (dopamine causes negative and positive symptoms of schizophrenia;
antipsychotics block D2 receptors to reduce these symptoms).
1. Dopamine hypothesis: mesolimbic hyperactivity → positive symptoms; mesocortical hypoactivity →
negative symptoms. Antipsychotics block D2 receptors primarily.
First generation antipsychotics improve _________ symptoms, and there is a higher risk of
developing _________.
Correct Answer: positive, hyperprolactinemia
1. FGAs block D2 in mesolimbic (improves positive symptoms) and tuberoinfundibular (causes
hyperprolactinemia) pathways. Negative symptoms less improved.
Which medication is a good option for a patient with schizophrenia who also suffers from
insomnia?
Correct Answer: Olanzapine (best tolerated antipsychotic, sedating properties due to histamine H1
antagonism).
1. Olanzapine: high sedation (H1 blockade), weight gain, metabolic syndrome. Use caution with insomnia
due to sedation timing (bedtime dosing).
What brain region is responsible for speech comprehension?
Correct Answer: Wernicke's Area (posterior superior temporal lobe).
1. Wernicke's aphasia: fluent but meaningless speech, poor comprehension. Broca's area (speech
production).
(Latest 2026/2027 Update) Neuroanatomy, CYP450,
Antipsychotics, Neurotransmitters | Q&A | Grade A | 100%
Correct Verified Answers
Subject: Advanced Psychopharmacology – Functional Neuroanatomy (Frontal Lobe, Wernicke's Area,
Broca's Area, Hippocampus, Basal Ganglia, Limbic System, Temporal Lobe, Occipital Lobe,
Gray/White Matter); Neurotransmitters (Dopamine, Serotonin, Norepinephrine, GABA, Acetylcholine,
Glutamate); Dopamine Pathways (Mesolimbic, Nigrostriatal, Mesocortical, Tuberoinfundibular);
CYP450 Inducers/Inhibitors; Pharmacokinetics (Steady State, Half-Life); Pharmacodynamics (Agonist,
Partial Agonist, Antagonist, Inverse Agonist); First-Generation Antipsychotics (FGAs) – Positive
Symptoms, EPS, Hyperprolactinemia; Second-Generation Antipsychotics (SGAs) – Clozapine,
Risperidone, Olanzapine, Quetiapine, Aripiprazole, Lurasidone, Ziprasidone, Asenapine, Iloperidone,
Paliperidone; Adverse Effects (NMS, Tardive Dyskinesia, Akathisia, Dystonia, QT Prolongation,
Metabolic Syndrome); Beers Criteria; Epigenetics; Informed Consent; Extrapyramidal Symptoms
(EPS); Hyperprolactinemia; Galactorrhea; Smoking and Antipsychotic Metabolism; Grapefruit Juice
Interactions; Pharmacogenomics (Extensive Metabolizer, Poor Metabolizer, Rapid Metabolizer);
Tolerance; SSRI Discontinuation Syndrome.
Source: NR 546 Midterm Blueprint 2026, Stahl's Essential Psychopharmacology, APA Guidelines.
Format: Q&A Guide with Clinical Rationale | Verified Answers | Grade A Guaranteed
Which of the following data is most accurate in determining a treatment plan for a patient who
presents with depression?
Correct Answer: The patient states that they are experiencing feelings of sadness, insomnia, and
lack of appetite (subjective patient report is primary in depression diagnosis).
1. Depression diagnosis is clinical (DSM-5 criteria). Lab tests cannot diagnose depression. Patient-
reported symptoms guide treatment selection.
Informed Consent in psychiatric practice
Correct Answer: Clients have the right to receive enough information to make decisions about their
treatment. Must be informed about potential risks associated with medication. Clients have the right
to refuse treatment and cannot be forcibly medicated in non-emergencies.
1. Elements: disclosure of risks/benefits, alternatives, risks of no treatment; competency; voluntariness.
2. Exceptions: emergency (danger to self/others), court order, legally mandated treatment.
Which lobe is responsible for movement and intelligence and can result in personality changes
if damaged?
Correct Answer: Frontal Lobe
1. Frontal lobe: motor cortex, executive function (planning, organization, abstract thinking), personality,
behavior, emotional control. Damage causes personality changes, disinhibition, apathy, poor judgment.
, PMHNP wants to prescribe olanzapine for depression. Client takes amiodarone for atrial
fibrillation. What does PMHNP need to do?
Correct Answer: Decrease the dosage of olanzapine (amiodarone is CYP450 inhibitor, reduces
olanzapine metabolism, risk of toxicity).
1. Amiodarone inhibits CYP3A4, CYP2D6, CYP2C9. Olanzapine metabolized by CYP1A2, CYP2D6.
Inhibition leads to increased olanzapine levels.
What NTM is responsible for a patient's diagnosis of Parkinson's?
Correct Answer: Dopamine (low dopamine in nigrostriatal pathway causes Parkinson's motor
symptoms).
1. Dopamine affects balance and coordination. Low levels found in Parkinson's. Treatment:
levodopa/carbidopa, dopamine agonists.
Where does Naloxone fall on the agonist spectrum?
Correct Answer: Antagonist (binds to opioid receptors, blocks endogenous opioids, no intrinsic
activity, reverses opioid effects).
1. Naloxone is competitive antagonist at mu-opioid receptor. Precipitates withdrawal in opioid-dependent
patients.
Medications for schizophrenia target which main neurotransmitter?
Correct Answer: Dopamine (dopamine causes negative and positive symptoms of schizophrenia;
antipsychotics block D2 receptors to reduce these symptoms).
1. Dopamine hypothesis: mesolimbic hyperactivity → positive symptoms; mesocortical hypoactivity →
negative symptoms. Antipsychotics block D2 receptors primarily.
First generation antipsychotics improve _________ symptoms, and there is a higher risk of
developing _________.
Correct Answer: positive, hyperprolactinemia
1. FGAs block D2 in mesolimbic (improves positive symptoms) and tuberoinfundibular (causes
hyperprolactinemia) pathways. Negative symptoms less improved.
Which medication is a good option for a patient with schizophrenia who also suffers from
insomnia?
Correct Answer: Olanzapine (best tolerated antipsychotic, sedating properties due to histamine H1
antagonism).
1. Olanzapine: high sedation (H1 blockade), weight gain, metabolic syndrome. Use caution with insomnia
due to sedation timing (bedtime dosing).
What brain region is responsible for speech comprehension?
Correct Answer: Wernicke's Area (posterior superior temporal lobe).
1. Wernicke's aphasia: fluent but meaningless speech, poor comprehension. Broca's area (speech
production).
